Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-24-001146
Filing Date
2024-05-15
Accepted
2024-05-15 14:56:12
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20240331.htm   iXBRL 10-Q 449479
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 8539
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4448
  Complete submission text file 0001096906-24-001146.txt   2612437

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20240331_cal.xml EX-101.CAL 18164
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20240331_def.xml EX-101.DEF 57770
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20240331_lab.xml EX-101.LAB 141407
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20240331_pre.xml EX-101.PRE 133584
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20240331.xsd EX-101.SCH 34618
68 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20240331_htm.xml XML 354730
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 24949589
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)